The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a call for evidence to evaluate the impact of resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and is due to close on 26 February 2027.
The two organisations are seeking feedback from a broad range of stakeholders: developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers and regulators, alongside people with lived experience of mental health conditions, carers and members of the public.
The exercise forms part of the programme's Phase 1 evaluation. According to MHRA and NICE, its purpose is to establish how the resources have been received and used across the sector, and in particular whether the materials have influenced users' knowledge, confidence, decision-making and professional practice.
The resources were developed to support the safe development, regulation, evaluation and adoption of digital mental health technologies, a category that includes mental health apps and other digital tools.
Findings from the survey will be used to judge whether the Phase 1 outputs achieved their intended objectives and to inform the future direction of Phase 2 of the DMHT programme. The agencies said the feedback would help identify strengths, highlight areas for improvement and shape later work aimed at improving the safety and effectiveness of digital mental health technologies.
Stakeholders are encouraged to take part whether they have engaged extensively, minimally or not at all with the existing resources.